These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6308686)

  • 1. Penicillin induced human platelet dysfunction and its reversal by epinephrine.
    Rao GH; Reddy KR; White JG
    Prostaglandins Leukot Med; 1983 Jun; 11(2):199-211. PubMed ID: 6308686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface.
    Shattil SJ; Bennett JS; McDonough M; Turnbull J
    J Clin Invest; 1980 Feb; 65(2):329-37. PubMed ID: 6243309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactam antibiotic-induced platelet dysfunction: evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin.
    Burroughs SF; Johnson GJ
    Blood; 1990 Apr; 75(7):1473-80. PubMed ID: 2180496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
    Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
    Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function.
    Rao GH; Radha E; White JG
    Biochem Biophys Res Commun; 1983 Dec; 117(2):549-55. PubMed ID: 6229254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of phospholipase A2 on human blood platelet alpha adrenergic receptor function.
    Rao GH; White JG
    Thromb Res; 1989 Mar; 53(5):427-34. PubMed ID: 2544037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose aspirin, platelet function and prostaglandin synthesis: influence of epinephrine and alpha adrenergic blockade.
    Rao GH; Reddy RK; White JG
    Prostaglandins Med; 1981 May; 6(5):485-94. PubMed ID: 6115432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration.
    Violi F; Pratico D; Ghiselli A; Alessandri C; Iuliano L; Cordova C; Balsano F
    Atherosclerosis; 1990 Jun; 82(3):247-52. PubMed ID: 2115784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epinephrine potentiates human platelet activation but is not an aggregating agent.
    Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible platelet aggregation does not depend on lipoxygenase metabolites.
    Rao GH; Radha E; White JG
    Biochem Biophys Res Commun; 1985 Aug; 131(1):50-7. PubMed ID: 3929780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation independent of ADP release or prostaglandin synthesis in patients with hermansky-Pudlak syndrome.
    Rao GH; Gerrard JM; Witkop CJ; White JG
    Prostaglandins Med; 1981 Apr; 6(4):459-72. PubMed ID: 7280120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of various doses of aspirin (in vivo) on platelet arachidonic acid metabolism (ex vivo) and function.
    Rao GH; White JG
    Prostaglandins Leukot Essent Fatty Acids; 1994 Jul; 51(1):63-7. PubMed ID: 7938101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on human platelets of catecholamines at levels achieved in the circulation.
    Ardlie NG; McGuiness JA; Garrett JJ
    Atherosclerosis; 1985 Dec; 58(1-3):251-9. PubMed ID: 3004519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity.
    Hirakata H; Ushikubi F; Toda H; Nakamura K; Sai S; Urabe N; Hatano Y; Narumiya S; Mori K
    Anesthesiology; 1996 Dec; 85(6):1447-53. PubMed ID: 8968193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.